Huping Jiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Huping Jiao has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Ang Su
4 shared publicationsDaxin Pang
4 shared publicationsDongmei Lv
4 shared publicationsHaisi Dong
4 shared publications- Hongsheng Ouyang
College of Animal Sciences, Jilin University, Changchun 130062, China
4 shared publications Jianwei Dong
4 shared publications
Latest Publications
- Open Access
- 6 October 2022
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 54 (2) , 182-189
A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2
Objective: The outbreak of COVID-19 caused by SARS-CoV-2 has led to a serious worldwide pandemic. Quantitative reverse transcription–polymerase chain reaction (qRT-PCR)–based methods were recommended for routine detection of SARS-CoV-2 RNA. Because the reaction time and analytical sensitivity of qRT-PCR limits the diagnosis of SARS-CoV-2, development of a quick process of SARS-CoV-2 detection technology with high analytical sensitivity remains urgent.Methods: We combined isothermal amplification and fluorescence detection technology to develop a new auto-recombinase polymerase amplification (RPA)-fluorescence platform that could be used in the diagnosis of SARS-CoV-2.Results: By optimization of primers and probes, the RPA platform could detect SARS-CoV-2 nucleotides within 15 min. The limits of detection and specificity of the auto-RPA-fluorescence platform were 5 copies/µL and 100%, respectively. The accuracy of detection of the auto-RPA-fluorescence platform in the 16 positive samples was 100%.Conclusion: The RPA platform is a potential technology for the diagnosis of SARS-CoV-2 infection.
- 6 October 2022
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 54 (2) , 182-189
Open AccessA New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2
Objective: The outbreak of COVID-19 caused by SARS-CoV-2 has led to a serious worldwide pandemic. Quantitative reverse transcription–polymerase chain reaction (qRT-PCR)–based methods were recommended for routine detection of SARS-CoV-2 RNA. Because the reaction time and analytical sensitivity of qRT-PCR limits the diagnosis of SARS-CoV-2, development of a quick process of SARS-CoV-2 detection technology with high analytical sensitivity remains urgent.Methods: We combined isothermal amplification and fluorescence detection technology to develop a new auto-recombinase polymerase amplification (RPA)-fluorescence platform that could be used in the diagnosis of SARS-CoV-2.Results: By optimization of primers and probes, the RPA platform could detect SARS-CoV-2 nucleotides within 15 min. The limits of detection and specificity of the auto-RPA-fluorescence platform were 5 copies/µL and 100%, respectively. The accuracy of detection of the auto-RPA-fluorescence platform in the 16 positive samples was 100%.Conclusion: The RPA platform is a potential technology for the diagnosis of SARS-CoV-2 infection.
- 31 May 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (25) , 22164-22170
Biomimetic Octopus-like Particles for Ultraspecific Capture and Detection of Pathogens
Infectious diseases caused by pathogenic bacteria (such as sepsis and meningitis) seriously threaten public health, rapid and accurate identification of target bacteria is urgently needed to prevent and treat bacterial infections. Although technologies including plate-counting and polymerase chain reaction have been established to detect the pathogenic bacteria, they are either time-consuming or sophisticated. Herein, a biomimetic octopus-like structure integrated merits of multiarm and multivalent interaction is designed for ultra-specific capture and detection of pathogens. The flexible polymeric arms and multivalent ligands work together to mimic the arm-sucker coordination of octopus in effectively grasping of targeting pathogens, leading to a remarkably high capacity and specificity for target capture (above 98%, 10 CFU mL−1) without nonspecific absorption of background pathogens. The captured bacteria can be identified point-of-care by the surface-enhanced Raman spectroscopy (SERS) method with a detection limit of 10 cells mL−1.
- 31 May 2019
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (25) , 22164-22170
Biomimetic Octopus-like Particles for Ultraspecific Capture and Detection of Pathogens
Infectious diseases caused by pathogenic bacteria (such as sepsis and meningitis) seriously threaten public health, rapid and accurate identification of target bacteria is urgently needed to prevent and treat bacterial infections. Although technologies including plate-counting and polymerase chain reaction have been established to detect the pathogenic bacteria, they are either time-consuming or sophisticated. Herein, a biomimetic octopus-like structure integrated merits of multiarm and multivalent interaction is designed for ultra-specific capture and detection of pathogens. The flexible polymeric arms and multivalent ligands work together to mimic the arm-sucker coordination of octopus in effectively grasping of targeting pathogens, leading to a remarkably high capacity and specificity for target capture (above 98%, 10 CFU mL−1) without nonspecific absorption of background pathogens. The captured bacteria can be identified point-of-care by the surface-enhanced Raman spectroscopy (SERS) method with a detection limit of 10 cells mL−1.
- 18 April 2019
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (9) , 6172-6179
Magnetic Multiarm Scaffold for the One-Step Purification of Epitope-Specific Neutralizing Antibodies
Epitope-specific neutralizing antibodies (EsAbs) are of prime importance in the diagnosis and treatment of various serious diseases. However, obtaining EsAbs by the monoclonal antibody technique involves time-consuming and sophisticated multistep procedures, and the epitopes of the resulting antibodies are often not explicit. It is also very challenging to isolate EsAbs from numerous kinds of total immunoglobulins because of nonspecific adsorption and low separation efficiency. Herein, a magnetic core@multiarm shell-epitope (M@A-E) bioconjugate was fabricated to enrich and isolate EsAbs from immune serums. This robust multiarm scaffold exhibits outstanding binding capacity and good resistance to nontarget adsorption and serves as a reservoir for the release and reloading of EsAbs for repeatable applications. The EsAbs yield per miligrama of the M@A-E was about 30 μg, which was approximately as twice as that of commercially available beads (16 μg). After 10 cycles of loading and release in glycine buffer (0.1 M, pH 2.5), the M@A-E bioconjugates still showed relatively high specificity and capture capacity (20 μg) that superior to the same amount of new, unused conventional ones. This strategy provides a promising platform for enriching and isolating substantial quantities of EsAbs, which have great potential for applications in the detection and treatment of critical illness.
- 18 April 2019
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (9) , 6172-6179
Magnetic Multiarm Scaffold for the One-Step Purification of Epitope-Specific Neutralizing Antibodies
Epitope-specific neutralizing antibodies (EsAbs) are of prime importance in the diagnosis and treatment of various serious diseases. However, obtaining EsAbs by the monoclonal antibody technique involves time-consuming and sophisticated multistep procedures, and the epitopes of the resulting antibodies are often not explicit. It is also very challenging to isolate EsAbs from numerous kinds of total immunoglobulins because of nonspecific adsorption and low separation efficiency. Herein, a magnetic core@multiarm shell-epitope (M@A-E) bioconjugate was fabricated to enrich and isolate EsAbs from immune serums. This robust multiarm scaffold exhibits outstanding binding capacity and good resistance to nontarget adsorption and serves as a reservoir for the release and reloading of EsAbs for repeatable applications. The EsAbs yield per miligrama of the M@A-E was about 30 μg, which was approximately as twice as that of commercially available beads (16 μg). After 10 cycles of loading and release in glycine buffer (0.1 M, pH 2.5), the M@A-E bioconjugates still showed relatively high specificity and capture capacity (20 μg) that superior to the same amount of new, unused conventional ones. This strategy provides a promising platform for enriching and isolating substantial quantities of EsAbs, which have great potential for applications in the detection and treatment of critical illness.
- 2 April 2019
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 8 (5) , 989-1000
Development of Whole-Porcine Monoclonal Antibodies with Potent Neutralization Activity against Classical Swine Fever Virus from Single B Cells
Classical swine fever (CSF) is a highly contagious swine disease that causes devastating economic losses. However, there are few efficacious therapeutic antibodies against the CSF virus (CSFV). Accordingly, we isolated two whole-porcine anti-CSFV neutralizing antibodies (NAbs) directly from single B cells sorted using the conserved linear epitope of the CSFV E2 protein and goat anti-pig IgG. These mAbs, termed HK24 and HK44, can bind to the E2 protein by recognizing sites within the conserved linear epitope of E2. In addition, these two mAbs can detect virus infection with high specificity and possess potent neutralizing activity. MAbs HK24 and HK44 protect PK-15 cells from CSFV infections in vitro with potent IC50 values of 9.3 μg/ml and 0.62 μg/ml, respectively. We anticipate that these antibodies can be used as diagnostic and antiviral agents for CSFV and that the method we describe here will accelerate the production of therapeutic antibodies for other viruses. Keywords: Classical swine fever; epitope of E2 protein; whole-porcine anti-CSFV neutralizing antibodies; single B cells
- 2 April 2019
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 8 (5) , 989-1000
Development of Whole-Porcine Monoclonal Antibodies with Potent Neutralization Activity against Classical Swine Fever Virus from Single B Cells
Classical swine fever (CSF) is a highly contagious swine disease that causes devastating economic losses. However, there are few efficacious therapeutic antibodies against the CSF virus (CSFV). Accordingly, we isolated two whole-porcine anti-CSFV neutralizing antibodies (NAbs) directly from single B cells sorted using the conserved linear epitope of the CSFV E2 protein and goat anti-pig IgG. These mAbs, termed HK24 and HK44, can bind to the E2 protein by recognizing sites within the conserved linear epitope of E2. In addition, these two mAbs can detect virus infection with high specificity and possess potent neutralizing activity. MAbs HK24 and HK44 protect PK-15 cells from CSFV infections in vitro with potent IC50 values of 9.3 μg/ml and 0.62 μg/ml, respectively. We anticipate that these antibodies can be used as diagnostic and antiviral agents for CSFV and that the method we describe here will accelerate the production of therapeutic antibodies for other viruses. Keywords: Classical swine fever; epitope of E2 protein; whole-porcine anti-CSFV neutralizing antibodies; single B cells